Annals of internal medicine
-
Type 2 diabetes mellitus is associated with a heavy burden of suffering. Screening for diabetes is controversial. ⋯ The interventions that are most clearly beneficial during the preclinical phase are those that affect the risk for cardiovascular disease. The magnitude of additional benefit of initiating tight glycemic control during the preclinical phase is uncertain but probably small.